Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Invokana“
Suchtreffer
Begriffe & Kennungen
Invokana · 4.5 · Inhibition of BCRP by canagliflozin cannot be excluded at an intestinal level and increased exposure may there
Eintrag öffnenInvokana · 4.5 · Insulin and insulin secretagogues
Eintrag öffnenInvokana · 4.5 · Insulin and insulin secretagogues, such as sulphonylureas, can cause hypoglycaemia. Therefore, a lower dose of
Eintrag öffnenInvokana · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenInvokana · 4.5 · Interaction studies suggest that the pharmacokinetics of canagliflozin are not altered by metformin, hydrochlo
Eintrag öffnenInvokana · 4.5 · Medicinal product/Laboratory test interference
Eintrag öffnenInvokana · 4.5 · Paediatric population
Eintrag öffnenInvokana · 4.5 · Pharmacodynamic interactions
Eintrag öffnenInvokana · 4.5 · Pharmacokinetic interactions
Eintrag öffnenInvokana · 4.5 · Simvastatin The combination of canagliflozin 300 mg once daily for 6 days with a single dose of simvastatin (C
Eintrag öffnenInvokana · 4.5 · The metabolism of canagliflozin is primarily via glucuronide conjugation mediated by UDP glucuronosyl transfer
Eintrag öffnenInvokana · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenInvokana · 4.8 Undesirable effects · 1
Eintrag öffnenInvokana · 4.8 · 10 not known Necrotising fasciitis of the perineum (Fournier’s gangrene)d Immune system disorders rare Anaphyl
Eintrag öffnenInvokana · 4.8 · 11 a Related to volume depletion; see section 4.4 and description of adverse reaction (AR) below. b See sectio
Eintrag öffnenInvokana · 4.8 · 12 canagliflozin, which enrolled a general diabetic population of 8,114 adult patients, no difference in lower
Eintrag öffnenInvokana · 4.8 · 13 placebo group (2.60 events per 100 patient-years); however, in the subgroups eGFR ≥45 to <60 and eGFR 60 to
Eintrag öffnenInvokana · 4.8 · 14 In two other long-term studies in adults and in studies in adults conducted in the general diabetes populat
Eintrag öffnenInvokana · 4.8 · 15 per 100 patient-years). Serious and severe renal-related events were also lower in the canagliflozin group
Eintrag öffnenInvokana · 4.8 · Adverse reactions in table 2 are based on the pooled analysis of the placebo- and active-controlled studies de
Eintrag öffnen